Skip to main content
Fig. 7 | BMC Complementary Medicine and Therapies

Fig. 7

From: Thymol protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson’s disease via inhibiting oxidative stress

Fig. 7

Effects of the intraperitoneal administration of thymol for 15 days on 6- OHDA-induced motor impairment. Apomorphine-induced rotational behavior (a), time in the bar test (b), motor coordination, and balance in the pole test: both inversion and total time (c, d) and the beam walking test (e, f). The values are presented by means ± SEM for six rats in each group. *p < 0.05 and ***p < 0.001 versus the untreated control group; #p < 0.05 and ##p < 0.01 and ###p < 0.001 versus the 6-OHDA-treated groups

Back to article page